INS and type 2 diabetes mellitus: The principal treatments for T2DM patients include insulin secretagogues, biguanides, insulin sensitizers, alpha-glucosidase inhibitors, incretin mimetics, amylin antagonists, and sodium-dependent glucose cotransporter proteins-2 (SGLT-2) inhibitors [4].